Therapy Areas: Infectious Diseases
AbCellera Signs Agreement with Global Health Foundation to Fight Infectious Disease
15 March 2019 - - Canada-based therapeutic antibodies developer AbCellera has inked a two-year agreement with the Bill and Melinda Gates Foundation to help accelerate global health research, the ...
Neoviva Project Supporting the Development of myvacAwarded a EUR 5.2m Grant from Bpifrance's "Investments for the Future" Programme
...
Inovio Pharmaceuticals incurs higher net loss of USD97.0m in 2018
13 March 2019 - Biotechnology company Inovio Pharmaceuticals Inc (NASDAQ:INO) stated on Tuesday its net loss of USD97.0m (USD1.05 per basic and diluted share) for the year ended 31 December 2018.This ...
Bavarian Nordic reports on US FDA delay in the review of the BLA for its MVA-BN smallpox vaccine
12 March 2019 - Bavarian Nordic A/S (CPH:BAVA), a fully integrated biotechnology company focused on the development of therapies against cancer and infectious diseases, announced on Monday the receipt...
Alnylam Submits CTA Application for ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension in High Unmet Need Settings
11 March 2019 - - US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) has submitted a clinical trial authorization application to The Medicines and Healthcare products...
Boehringer Ingelheim Says Novel Antibody Shows Potential to Transform Treatment of Rare Form of Psoriasis
8 March 2019 - - The New England Journal of Medicine has published new data from a Phase I clinical trial showing BI 655130, a first-in-class investigational treatment, significantly improved sym...